Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TBUFF Very interesting developments here at TBUFF, back on Radar Watch....Kind regards, Gums~~~~~~~~~~$$
0,433 bullish golden across today!
now we have a solid support to start the ride to one buck.
...to follow, Bezalip approval should send Tbuff into 3-5 dollars land.
enjoy!
http://stockcharts.com/h-sc/ui?s=TBUFF
Just wanted to say hi to the board...Ive started accumulation on this stock. But I was curious..how is the 20billion dollar market for Bezalip calculated? Thats pretty big.
agree, extremely undervalued...2 buck at least( 100 mill mkt.cap.)
TBUFF is brutally Undervalued Gem
New Presentation
http://content.stockpr.com/tributepharma/media/0a26f60f9fe2b220d091c62d6123d81e.pdf
Summary
Canadian Business Includes 7 Marketed Products Including Recently Launched CAMBIA
Tribute sells products in both the primary care and specialty care markets.CAMBIA was launched in October 2012 to compete in the $150 million Canadian migraine market and is expected to be a key contributor to revenue growth in 2013.CAMBIA is a novel, patent-protected, fast-acting, new treatment option for people suffering from acute migraine attacks.Tribute has also entered into a promotional agreement with Pfizer Canada for the exclusive Canadian promotional rights to Gelfoam® in Canada. MycoVa is currently pending regulatory approval in Canada.
MEGA Product Pipeline :
Product Indication Geographic Right Market Size
Bezalip® SR Mixed dyslipidemia US & Canada $20 B
NeoVisc® Osteoarthritis of the knee Global $1.4 B
Soriatane® Moderate to severe psoriasis Canada $210 M
Uracyst® Interstitial cystitis Global $151 M
CAMBIA® Acute migraine headaches Canada $150 M
Collatamp G® Prevention of post-operative infection Canada $20 M
Gelfoam® Hemostatic device Canada $30 M
MycoVa™ Nail fungus Canada $30 M
Robert Harris - President &Chief Executive Officer
Founder of privately-held Tribute Pharmaceuticals which was acquired by the Company in 2011. Pharmaceutical industry veteran. Held executive positions at Biovail Corporation including VP of Business Development and GM of Biovail’s Canadian commercial group ,where he helped grow revenues to $150 M within four years, leading to Biovail’s acquisition by Valeant (NYSE:VRX) for $3.2 billion.20 years at Wyeth, now division of Pfizer (NYSE:PFE),where as Director of Sale s of Specialty Care group he built out Canadian market segment.Mr. Harris owns 20% of Tribute.
John Gregory- Director
Founded and built King Pharmaceuticals (formerly NYSE:KG) which was recently sold to Pfizer (NYSE:PFE) for $3.6 billion. Grew company from small family business to the world‘s 39th largest pharma company that was
included in S&P 500 Index with revenues over $1 billion.Now managing partner of SJ Strategic Investments , a family owned investment management firm. Mr. Gregory owns 12% of Tribute.
TBUFF´s Major Shareholders :
Elora Financial ... 6.8M
SJ Strategic ...6.4M
Harris (Robert) ....4.8M
Harris (Mary-Ann)... 4.1M
Goldman (Steven H) ....2.5M
Gregory (John M) ...1.7M
Thrasher ...1.3M
Tenney (Arnold)...1.2M
Kime (John J) ....125.0K
Clarke (Janice ...90.4K
Why the sudden activity here today?? I've been holding this one for a while now....
and we now go green! looking good, trend is in place!
ouch 5050 traded at .37 real quick somoeone lost money on a market order. right back to .53 offer and a show that this is going higher MM looking to shake the tree before going higher in my humble opinion.
I agree. Real nice!
looks new base at .47 to .50 lets break high of .75 head towards 1.00+
bought some more today, looks like apause from the run but selling is light whoever bought the run was an investor from the looks of it.
TBUFF $$$ I am of the mind that TBUFF will be testing the upper .50's today, I think the undue and unnatural drop in SP, and my guess is as good as another, was just retail transferring funds into liquid cash for what ever projects they are off to.
resist. 0.74 3
resist. 0.62 3
resist. 0.59 3
resist. 0.57 2
resist. 0.54 3
supp 0.49 3
supp 0.39 111
supp 0.00 61
Very strong support at .39, but I doubt the Board members want this to slide that low, some bought in at higher levels. I hope that TBUFF powers through that .57 .59 range. Could close at .61, restoring confidence to any retail. Larger investors are ten moves ahead, and know when they will be cashing in, papers on the porch.
I bought some today. My cost basis is still pretty low.
good opportunity to add light volumn sell off - oppose to heavy buying. temp. shakeout
TBUFF Just weird about the selling at this level. I know some are in @ .30's, so they could be taking profit. Nothing about the Company has changed, and the 8K was fine. TBUFF is a solid play for higher SP. If I had more dry powder would be a buyer at this level. TBUFF $$$$$
That's right. JAZZ was once in the Pennyland. And now it's in the $80.00+. I'm in this all the way.
Great looking company. I'm curious, are they going to have to do trials for Bezalip in the US (possibly a confirmatory phase 3?). Just wondering how long it would take them to get Bezalip to the US market. This looks like a minature JAZZ in the making. JAZZ had the same type of business model and look where they are now.
TBUFF Wow cannot believe only 100 shares traded today. I know half the story is retail holders,(like me) would not even think of selling for the bid @.55, its a joke. My shares are locked at higher levels $$$. Just do not know why TBUFF is not popping with what it has to offer. I bought a Bull not a wallflower, someone step into it, hard. TBUFF $$$$$
light the fuse, could happen anytime, no one to miss the boom
No volume. Bigger fish want retail out, the longer no volume, the better chance of a retail shake out, then buy in. TBUFF $$$$
TBUFF O.K. TBUFF lets see what your really made of! Greatness I know from all my DD. TBUFF get in/more on this pullback. Back in the .70's minimum this week! TBUFF $$$$$$
don't see a reverse as no need to and higher exchange i can see once we go higher which i think it will. hope that helps
Market Capitalization: 19.88 Million
Issued Shares: 50.9 Million
Fully Diluted Shares: 68.5 Million
Float Shares: 22 Million
Insider and Institutional Ownership: 57%
Plans for converting to higher exchange?
Saw this on the IMUC board and started DD on it. Looks great. Was wondering what/when this will get off the OTC and get on a higher exchange. I realize the cost is high, but they have revenue to do it.
Also, any plans for a reverse split to get the PPS higher? Don't mistake me for a basher. I also own NBS who just did that last month and it didn't hurt them at all. They also moved to the NASDAQ with the benefits that incurs.
Thanks,
Bob
Burn-Rate is down Revenue is up and they have enough cash to drive this Goldmine deep into profitability .
Stock was overbought so this pullback is no surprise .
Everything is on track ...Good Buy here
It's more than impressive. It's amazing.
typical sell on the news but i think investors are buying it up and will go much higher soon!
EXCELLENT! Simply amazing & more to come.
Retail shake out then big buyer comes in for 50 to 100k shares. TBUFF $$$$ The 8K is great, the walk down is BS.
Nice Financing: towards bottom:
http://finance.yahoo.com/news/tribute-pharmaceuticals-announces-double-digit-135122800.html
On August 8, 2013, SWK Funding LLC ("SWK"), a wholly-owned subsidiary of SWK Holdings Corporation entered into a credit agreement (the "Credit Agreement") pursuant to which the lenders party thereto provided to the Company a term loan in the principal amount of US$6,000,000 (the "Loan") which may be increased by an additional US$2,000,000 at the Company's request on or before December 31, 2014. SWK served as the agent, under the Credit Agreement. The Loan matures on August 8, 2018 and accrues interest at an annual rate of 11.5% plus the Libor Rate (as defined in the Credit Agreement), with the Libor Rate being subject to a minimum floor of 2%, such that that minimum interest rate is 13.5%. Pursuant to the terms of the Credit Agreement, the Company entered into a Guaranty and Collateral Agreement granting the Lenders a security interest in substantially all of the Company's assets. In connection with the Loan, the Company issued SWK Funding 755,794 common share purchase warrants with each warrant entitling SWK Funding to acquire one common share in the capital of the Company at an exercise price of US$0.5954, exercisable at any time prior to August 8, 2020. In connection with Loan, the Company exercised its rights under the MidCap agreement to prepay the outstanding balance of the term loan with Midcap.
Tribute Pharmaceuticals Announces Double Digit Growth in Second Quarter 2013
http://finance.yahoo.com/news/tribute-pharmaceuticals-announces-double-digit-135122800.html
TBUFF light retail, looking for that Shark that set up this low entry point to bite, were going to need a bigger boat. TBUFF $$$$$
TBUFF 8K $$$ The 8K is hard to make out but I did read revenue and profits up 15%. TBUFF $$$$
TBUFF $$$ I think we will see a large buyer in the AM. Someone wanted in for a better price point. TBUFF
looks like a pause, some investor came in to buy, that run was not traders. waiting for next leg up :)
TBUFF volume is always predictable with TBUFF. Not heavy, a little retail taking nibbles or selling, then wham(!!), a big hit for 50,000 shares or 25k. Anyone take a guess at where the float is? 10 million to 25??? TBUFF $$$$$
Canadian Company so it has the bonus of not being in lock step with the American Trading Markets. Man what a beating some other BIO Tech's got IN* and AST* and the big looser SVF*. Notice the heading that this Company is listed under Medical-Drugs. It's not a BIO Tech per say. Anyone new can just refer to my older postings. Good play here with TBUFF $$$$$
Thank you, how are the financials for this company? I know all bios are risky but I'm looking to invest in a company that has good product, pipeline, management and financials that make sense! New to investing just trying to be a little cautious
Potential is unlimited... Good pipeline good management growth is starting next is profitability!!!!
I'm looking for a good buying opportunity on this one. Stumbled across this company and found it interesting! What's the possible potential here.....
nice breather, setting new floor at .65
couldn't agree more
Followers
|
20
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
580
|
Created
|
10/21/08
|
Type
|
Free
|
Moderators |
Tribute Pharmaceuticals Canada Inc. (“Tribute”) is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the US. The Company targets several therapeutic areas but has a particular interest in products for the treatment of pain, neurology, dermatology, cardiology, endocrinology and specialty care. Tribute also sells Uracyst® and NeoVisc® internationally through a number of strategic partnerships. Tribute currently markets NeoVisc® Single Dose, NeoVisc® Triple Dose, Uracyst®, Soriatane®, Bezalip® SR, Cambia®, Fiorinal®, Fiorinal® C, Visken® and Viskazide in Canada and has the US rights to Bezalip® SR and global rights to Uracyst® and NeoVisc® Additionally, Tribute has the exclusive Canadian rights to bilastine in Canada (not yet approved).
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |